Regulation of morphogenesis in C. albicans
白色念珠菌形态发生的调控
基本信息
- 批准号:9312992
- 负责人:
- 金额:$ 22.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-02-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmphotericinAntifungal AgentsAntifungal TherapyAntioxidantsAzolesCandida albicansCell WallCell membraneCellsComplexCopperCytoplasmic TailDefectDevelopmentDrug resistanceEffectivenessEnergy MetabolismEnvironmentExtracellular DomainFlavodoxinFluconazoleGene ProteinsGoalsGrantGrowthHigh temperature of physical objectHospitalsHumanImpairmentIndividualInfectionIntegral Membrane ProteinLipid PeroxidationLipid PeroxidesLipidsMammalian CellMediatingMedicalMembraneMembrane ProteinsMicrobial BiofilmsMitochondriaMorphogenesisMutagenesisMutationMycosesNutrientOrganOrganismOxidative StressPathogenesisPathogenicityPathway interactionsPeripheralPharmaceutical PreparationsPlayProcessProtein FamilyProteinsQuinone ReductasesRegulationResistanceRoleSERPINA4 geneSepsisStressSystemic infectionTemperatureTestingTherapeuticTherapeutic InterventionTimeTissuesTransmembrane DomainUbiquinoneVirulenceVirulence Factorsaging populationantimicrobial peptideextracellularfungusimprovedin vivomutantnew therapeutic targetnovelnovel therapeutic interventionoxidationpathogenpreventresistant strainrole modelsuccessuptake
项目摘要
Candida albicans is the most common cause of mucosal and systemic fungal infections in humans
and is frequently responsible for hospital-acquired bloodstream infections. There is an urgent need to
improve the therapeutic management of C. albicans infections, since current antifungal drugs have
limited effectiveness and drug-resistant strains are emerging. The pathogenic effects of C. albicans
are caused by its ability to grow in the host and disseminate to internal organs. Central to these
processes is the plasma membrane, an essential barrier that mediates a broad range of functions that
are critical for virulence. These functions include cell wall synthesis, secretion of virulence factors,
morphogenesis, and nutrient uptake. The importance of the plasma membrane for virulence is
underscored by the fact that it is directly or indirectly the target of the currently used antifungal drugs.
Recent studies have revealed that the fungal plasma membrane is divided into distinct subdomains,
including the punctate patches termed eisosomes. These 300 nm-sized domains contain integral
membrane proteins, such as Sur7, and an adjacent complex of >20 peripheral membrane proteins
including Pil1 and Lsp1 that promote formation of eisosomes. Our recent studies showed that Sur7,
Pil1, and Lsp1 are the key players in the eisosome, as their mutation causes multiple defects
including impaired cell wall synthesis, abnormal morphogenesis, and increased sensitivity to stress,
oxidation, and antifungal drugs. Therefore, the Aims of our current proposal are to determine how
eisosomes regulate three functions that are required for virulence: (Aim 1) cell wall synthesis and
invasive hyphal morphogenesis, (Aim 2) resistance to different types of stress including copper and
high temperature, and (Aim 3) a novel antioxidant pathway we discovered that protects the plasma
membrane from oxidation and is needed for virulence. The proposed studies will identify novel drug
targets and increase our understanding of the effects of current antifungal drugs. Defining eisosome
function in C. albicans will also provide a model for the role of these plasma membrane domains in
other pathogenic fungi.
白色念珠菌是人类粘膜和全身真菌感染的最常见原因
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James B Konopka其他文献
James B Konopka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James B Konopka', 18)}}的其他基金
Signal pathways controlling the bud to hypha transition
控制芽到菌丝转变的信号通路
- 批准号:
9912167 - 财政年份:2015
- 资助金额:
$ 22.01万 - 项目类别:
Signal pathways controlling the bud to hypha transition
控制芽到菌丝转变的信号通路
- 批准号:
10406353 - 财政年份:2015
- 资助金额:
$ 22.01万 - 项目类别:
C. albicans invasive growth promotes oropharyngeal infections
白色念珠菌侵入性生长促进口咽部感染
- 批准号:
9014539 - 财政年份:2015
- 资助金额:
$ 22.01万 - 项目类别:
Signal pathways controlling the bud to hypha transition
控制芽到菌丝转变的信号通路
- 批准号:
9752694 - 财政年份:2015
- 资助金额:
$ 22.01万 - 项目类别:
相似海外基金
有機分子触媒を用いたAmphotericin Bの合成研究
有机分子催化剂合成两性霉素B的研究
- 批准号:
24K17671 - 财政年份:2024
- 资助金额:
$ 22.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EnLAmB - Enabling global access to affordable generic liposomal amphotericin B injectable formulations via advanced manufacturing technology
EnLAmB - 通过先进的制造技术,使全球能够获得负担得起的通用脂质体两性霉素 B 注射制剂
- 批准号:
MR/X014010/1 - 财政年份:2023
- 资助金额:
$ 22.01万 - 项目类别:
Research Grant
Encochleated Oral Amphotericin for HIV-related Cryptococcal Meningitis Trial: Phase 3 Trial
包埋口服两性霉素治疗 HIV 相关隐球菌性脑膜炎试验:3 期试验
- 批准号:
10619788 - 财政年份:2023
- 资助金额:
$ 22.01万 - 项目类别:
Integrating genome-wide association study, quantitative trait loci mapping and transcriptome sequencing to identify genes associated with amphotericin B resistance in Aspergillus fumigatus
整合全基因组关联研究、数量性状基因座作图和转录组测序,鉴定与烟曲霉两性霉素 B 耐药性相关的基因
- 批准号:
559052-2021 - 财政年份:2022
- 资助金额:
$ 22.01万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Study on naturally-occurring peptides potentiating amphotericin B activity
天然存在的肽增强两性霉素 B 活性的研究
- 批准号:
22K05333 - 财政年份:2022
- 资助金额:
$ 22.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrating genome-wide association study, quantitative trait loci mapping and transcriptome sequencing to identify genes associated with amphotericin B resistance in Aspergillus fumigatus
整合全基因组关联研究、数量性状基因座作图和转录组测序,鉴定与烟曲霉两性霉素 B 耐药性相关的基因
- 批准号:
559052-2021 - 财政年份:2021
- 资助金额:
$ 22.01万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Amphotericin B Restoration of Anion Secretion in Cystic Fibrosis Airways
两性霉素 B 恢复囊性纤维化气道阴离子分泌
- 批准号:
10024667 - 财政年份:2020
- 资助金额:
$ 22.01万 - 项目类别:
Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections
NH101的开发:一种简单高效的门诊干粉两性霉素B-DryNeb(干粉雾化器),用于治疗敏感和多重耐药曲霉菌/真菌感染
- 批准号:
9909193 - 财政年份:2020
- 资助金额:
$ 22.01万 - 项目类别:
Amphotericin B Restoration of Anion Secretion in Cystic Fibrosis Airways
两性霉素 B 恢复囊性纤维化气道阴离子分泌
- 批准号:
10248529 - 财政年份:2020
- 资助金额:
$ 22.01万 - 项目类别:
Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections
NH101的开发:一种简单高效的门诊干粉两性霉素B-DryNeb(干粉雾化器),用于治疗敏感和多重耐药曲霉菌/真菌感染
- 批准号:
10484014 - 财政年份:2020
- 资助金额:
$ 22.01万 - 项目类别: